description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GCCTGAGAAGCCCATCATAGACAAGAAGTAGCAAACTGTACATTCCTTCTTCCTCCCCCTGCTCCAGAAGGTGCCGGTACTGAAGATGCTCCAGTAATTGGTGACCCAACCCTAGGAAGTAGGGAGAAATGAAGGAAGGGCATAGGAAAATTTTCCCAGTAAATCCCCTGATGGTCACATTAAGGTAAAGGTTTTGGCTGGTCAGTGTGCCAAGACCTCTCCAGCTTCTCATTCATGATGACCTCTCAAAGTTGGGAAACAAGCTGATTTCTTGCCAAGAGGTCTCCCAGGAGATATTTGGGAAATGTGAAGTTCGTATCTTTAAGGAGCATTTTTGGTCAGCATGGTTGATGAACTAATGATGAGAGAGTTAAGGAATGTTGCTAGAACATAGGGCTTGCTGGTACCTATGTGACTAAGAAAGGGACATGATGTAAGGGAAAAGGCCTCAA
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Liping Ye et al.
EMBO molecular medicine, 11(12), e10638-e10638 (2019-10-28)
Resistance to tamoxifen is a clinically major challenge in breast cancer treatment. Although downregulation of estrogen receptor-alpha (ERα) is the dominant mechanism of tamoxifen resistance, the reason for ERα decrease during tamoxifen therapy remains elusive. Herein, we reported that Spalt-like
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU072061-50UG | 04061828371952 |
| EHU072061-20UG | 04061828611522 |